Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menachem Laufer

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Israel Medical Association Journal : IMAJ|May 1, 2017
Salvage Radiation Therapy for Biochemical Failure Following Radical ProstatectomyBenjamin Spieler, Jeffrey Goldstein, Yaacov R Lawrence, et al.
Urology|January 31, 2004
Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of actionMario A Eisenberger, Menachem Laufer, Nicholas J Vogelzang, et al.
The Journal of Urology|July 4, 2014
A novel urine cytology stain for the detection and monitoring of bladder cancerNoa Davis, Yoram Mor, Pavel Idelevich, et al.
Asian Journal of Urology|December 30, 2025
Targeting bladder cancer: Potent anti-cancer effects of cannabichromene and delta-9-tetrahydrocannabinol-rich <i>Cannabis sativa</i> strainsOmer Anis, Vered Bar, Adi Zundelevich, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Israel Medical Association Journal : IMAJ|May 1, 2017
Salvage Radiation Therapy for Biochemical Failure Following Radical ProstatectomyBenjamin Spieler, Jeffrey Goldstein, Yaacov R Lawrence, et al.
Urology|January 31, 2004
Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of actionMario A Eisenberger, Menachem Laufer, Nicholas J Vogelzang, et al.
The Journal of Urology|July 4, 2014
A novel urine cytology stain for the detection and monitoring of bladder cancerNoa Davis, Yoram Mor, Pavel Idelevich, et al.
Asian Journal of Urology|December 30, 2025
Targeting bladder cancer: Potent anti-cancer effects of cannabichromene and delta-9-tetrahydrocannabinol-rich <i>Cannabis sativa</i> strainsOmer Anis, Vered Bar, Adi Zundelevich, et al.
Pageof 4